Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
Orderbuch | Analysen | |||||
Historisch | Ausblick |
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 99.77 |
The Vanguard Group, Inc. | 8.72 |
Vanguard Group, Inc. (Subfiler) | 8.70 |
SSgA Funds Management, Inc. | 5.65 |
State Street Corp. | 5.44 |
Capital Research & Management Co. (Global Investors) | 4.14 |
Vanguard Total Stock Market ETF | 3.11 |
BlackRock Fund Advisors | 3.09 |
PRIMECAP Management Co. | 2.75 |
Vanguard 500 Index Fund | 2.41 |
BlackRock Institutional Trust Co. NA | 2.30 |
Geode Capital Management LLC | 2.21 |
Charles Schwab Investment Management, Inc. | 2.10 |
Capital Research & Management Co. (Global Investors) | 1.79 |
Invesco QQQ Trust | 1.68 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 21'500 | 23'400 | 24'300 | 24'200 | 25'200 |
Umsatz pro Mitarbeiter in Mio. EUR | 1.11 | 0.99 | 1.04 | 1.07 | 1.04 |
Bilanz (in Mio. EUR) - Aktiva
2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 37'618 | 18'440 | 21'144 | 19'385 | 22'186 |
Summe Anlagevermögen | 46'429 | 40'104 | 42'854 | 40'679 | 43'301 |
Summe Aktiva | 66'416 | 59'707 | 62'948 | 61'165 | 65'121 |
Bilanz (in Mio. EUR) - Passiva
2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 33'929 | 30'431 | 33'445 | 33'979 | 39'640 |
Summe Fremdkapital | 53'916 | 50'034 | 53'539 | 54'465 | 61'460 |
Summe Eigenkapital | 12'500 | 9'673 | 9'409 | 6'700 | 3'661 |
Summe Passiva | 66'416 | 59'707 | 62'948 | 61'165 | 65'121 |
Adresse
One Amgen Center Drive, 91320-1799 Thousand Oaks | |
Telefon | +1 (805) 447-1000 |
Fax | +1 (805) 447-1010 |
URL | http://www.amgen.com |
Management
Amy E. Miles
Independent Director |
Arvind K. Sood
Vice President-Investor Relations |
Brian J. Druker
Independent Director |
Charles M. Holley
Independent Director |
Darryl Sleep
Chief Medical Officer & Senior VP-Global Medical |
David A. Piacquad
Senior Vice President |
David M. Reese
Executive Vice President-Research & Development |
Derek Miller
Chief Human Resources Officer |
Ellen Jamison Kullman
Independent Director |
Esteban Santos
Executive Vice President-Operations |
Greg C. Garland
Independent Director |
Jonathan P. Graham
Secretary, Executive VP & General Counsel |
Judy L. Brown
Senior Vice President-Corporate Affairs |
Linda H. Louie
Vice President-Finance |
Linda H. Louie
Chief Accounting Officer & Vice President-Finance |
Lori A. Johnston
Executive Vice President |
Mark J. Taisey
Senior VP-Global Regulatory Affairs & Strategy |
Matthew C. Busch
Chief Accounting Officer & Vice President-Finance |
Michael V. Drake
Independent Director |
Mike Zahigian
Chief Information Officer & Senior Vice President |
Murdo J. Gordon
EVP-Global Commercial Operations |
Nancy A. Grygiel
Chief Compliance Officer |
Omar Syed Ishrak
Independent Director |
Peter H. Griffith
Chief Financial Officer & Executive Vice President |
Rachna Khosla
Senior Vice President |
Robert A. Bradway
Chairman, President & Chief Executive Officer |
Robert A. Eckert
Lead Independent Director |
Robert Sanders Williams
Independent Director |
Robert T. Fremeau
Scientific Director |
Ronald D. Sugar
Independent Director |
Susan Sweeney
Senior VP-Global Marketing, Access & Capabilities |
Tyler E. Jacks
Independent Director |
Victoria H. Blatter
Senior Vice President-Global Government Affairs |
Wanda M. Austin
Independent Director |